(“Clearwater” or the “Company”), a leading worldwide provider of SaaS-based investment management, accounting, reporting, and analytics solutions, and Enfusion, Inc. (NYSE ...

Piper Sandler analyst Arvind Ramnani upgraded Clearwater Analytics to Overweight, increasing the price target to $36 from $28. CWAN's strong Q4 results exceeded revenue expectations, reporting $126.5M ...

NEW YORK CITY, NY / ACCESS Newswire / February 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics for $5.85 per ...

The Enfusion acquisition is anticipated to ... to realize the full potential of new products and acquisitions. Clearwater Analytics delivered a strong Q4 2024 performance, highlighted by robust ...

Clearwater Analytics Holdings Inc. (NYSE ... In that regard, on January 13, 2025, the company announced to acquire Enfusion (NYSE:ENFN) for $1.5 billion to strengthen its investment platform.

Fourth Quarter 2024 Financial Highlights: Fourth Quarter 2024 Business Highlights: Full Year 2024 Financial Highlights: Transaction with Clearwater Analytics On January 13, 2025, Enfusion ...

Investing.com -- Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share ...

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) (“Clearwater” or the “Company”), a leading worldwide provider of SaaS-based ...

Piper Sandler analyst Arvind Ramnani upgraded the shares of Clearwater Analytics Holdings Inc (NYSE ... 03 rise from the same period last year. The Enfusion acquisition is expected to finalize ...

Piper Sandler analyst Arvind Ramnani upgraded the shares of Clearwater Analytics Holdings Inc (NYSE ... the previous quarter and a $0.03 rise from the same period last year. The Enfusion acquisition ...